Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-control study-Reference-Cited by-同舟云学术

Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-control study

Published:2017-02-08 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Katchanov Juri,Kreuels Benno,Maurer Florian P.,Wöstmann Kai,Jochum Johannes,König Christina,Seoudy Kariem,Rohde Holger,Lohse Ansgar W.,Wichmann Dominic,Baehr Michael,Rothe Camilla,Kluge Stefan

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-017-2229-8.pdf

Reference23 articles.

1. Kollef MH. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care. 2005;9:459–64.

2. Daneman N, Gruneir A, Bronskill SE, Newman A, Fischer HD, Rochon PA, Anderson GM, Bell CM. Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med. 2013;173:673–82.

3. Sanden L, Paul M, Leibovici L, Andreassen S. Quantifying the associations between antibiotic exposure and resistance - a step towards personalised antibiograms. Eur J Clin Microbiol Infect Dis. 2016. [Epub ahead of print]

4. Leibovici L, Paul M, Garner P, Sinclair DJ, Afshari A, Pace NL, Cullum N, Williams HC, Smyth A, Skoetz N, Del Mar C, Schilder AG, Yahav D, Tovey D. Addressing resistance to antibiotics in systematic reviews of antibiotic interventions. J Antimicrob Chemother. 2016;71:2367–9.

5. Dalhoff K, Abele-Horn M, Andreas S, Bauer T, von Baum H, Deja M, Ewig S, Gastmeier P, Gatermann S, Gerlach H, Grabein B, Höffken G, Kern WV, Kramme E, Lange C, Lorenz J, Mayer K, Nachtigall I, Pletz M, Rohde G, Rosseau S, Schaaf B, Schaumann R, Schreiter D, Schütte H, Seifert H, Sitter H, Spies C, Welte T, German Society for Anaesthesiology and Intensive Care Medicine; German Society for Infectious Diseases; German Society for Hygiene and Microbiology; German Respiratory Society; Paul-Ehrlich-Society for Chemotherapy. [Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 guideline of the German society for anaesthesiology and intensive care medicine, the German society for infectious diseases, the German society for hygiene and microbiology, the German respiratory society and the Paul-Ehrlich-society for chemotherapy]. Pneumologie. 2012;66:707–65.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Treatment Failure and Mortality among Patients with Septic Shock Treated with Meropenem in the Intensive Care Unit;Malaysian Journal of Medical Sciences;2024-02-28

2. Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study;Scientific Reports;2023-09-04

3. Strategy of elimination of antibiotcoresistance to carbapenems – actual modern problem;Klinicheskaia khirurgiia;2022-12-14

4. Severe secondary peritonitis: impact of inappropriate initial antimicrobial therapy on prognosis and potential carbapenem-sparing;Minerva Anestesiologica;2022-05

5. Meropenem;Reactions Weekly;2017-09